Abstract
BackgroundInhibitors of tumor necrosis factor alpha (antiTNFα) represent a major advance in the treatment of many inflammatory-mediated diseases but are associated with an increased risk of infection, including tuberculosis (TB)....
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
